PEAK6 Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.36M Sell
12,596
-17,232
-58% -$1.88M 0.01% 1701
2018
Q1
$3.16M Buy
+29,828
New +$3.46M 0.01% 1086
2017
Q4
Sell
-6,532
Closed -$739K 4889
2017
Q3
$743K Buy
6,532
+2,789
+75% +$322K ﹤0.01% 2220
2017
Q2
$467K Buy
+3,743
New +$444K ﹤0.01% 2600
2017
Q1
Sell
-4,973
Closed -$564K 5108
2016
Q4
$498K Buy
+4,973
New +$533K ﹤0.01% 2520
2016
Q1
Sell
-8,099
Closed -$783K 5121
2015
Q4
$807K Sell
8,099
-15,831
-66% -$1.55M 0.01% 2133
2015
Q3
$2.18M Buy
+23,930
New +$2.4M 0.01% 1512
2015
Q2
Sell
-23,301
Closed -$2.58M 5548
2015
Q1
$2.66M Sell
23,301
-19,499
-46% -$2.22M 0.02% 1055
2014
Q4
$4.71M Buy
42,800
+40,795
+2,035% +$4.3M 0.04% 724
2014
Q3
$196K Buy
+2,005
New +$197K ﹤0.01% 3323
2014
Q2
Sell
-6,605
Closed -$644K 5220
2014
Q1
$607K Sell
6,605
-21,797
-77% -$2.01M 0.01% 2365
2013
Q4
$2.57M Buy
28,402
+6,010
+27% +$520K 0.02% 1246
2013
Q3
$894K Buy
22,392
+13,518
+152% +$1.06M 0.01% 2287
2013
Q2
$645 Buy
+8,874
New +$664K ﹤0.01% 2536

Other funds holding ZBH

PEAK6 Group's ZBH Position: Q2 2018 in Review

PEAK6 Group reduced its Zimmer Biomet (ZBH) stake by 58% in Q2 2018, selling an estimated $1.88M and leaving 12,596 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #1701.

PEAK6 Group first reported a position in ZBH in Q2 2013 and has held it in 14 quarters since. The position peaked at $4.71M in Q4 2014. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

  • PEAK6 Group held 12,596 shares of Zimmer Biomet worth $1.36M as of Q2 2018.
  • PEAK6 Group sold 17,232 Zimmer Biomet shares in Q2 2018, an estimated $1.88M.
  • Zimmer Biomet made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1701 holding.
  • PEAK6 Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 14 quarters since.
  • PEAK6 Group's Zimmer Biomet position peaked at $4.71M in Q4 2014.
  • 869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.